Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
| Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
|---|---|---|
| Current Price | $13.61 | $5.69 |
| Change | -0.37 (-2.65%) | -0.03 (-0.52%) |
| Market Cap | $1.05B | $0.25B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -5.06 | -9.81 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $17.00 | $20.90 |
| 52-Week Low | $4.92 | $5.47 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.07 | $-0.54 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| REPL | -0.58% | -0.58% | 58.07% | -9.93% | -10.22% | -10.22% |
| YMAB | -7.48% | -7.48% | -65.52% | -81.10% | -76.29% | -76.29% |